Heregulins are a family of growth factors encoded by 6 individual genes (NRG1-6) with NRG1 representing the archetypical growth factor ligand associated with poor prognosis in HER2-positive breast cancer [12, 28, 45]. Here, ERBB2 is linked to breast carcinoma.